Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

Hepatobiliary and Pancreatic Diseases International

Volumn 16, Issue 4, 2017, Pages 375-381

  Shen, Feng ^a   Zheng, Rui Dan ^c   Sun, Xing Qiang ^b,d   Ding, Wen Jin ^a   Wang, Xiao Ying ^a   Fan, Jian Gao ^a  

^a Department of Gastroenterology ^*  (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Department of Hepatology   (China)

^d BGI SHENZHEN   (China)

Author keywords

fatty liver disease; fibrosis; gut microbiota; non alcoholic steatohepatitis

Indexed keywords

ADULT; ARTICLE; BACTEROIDETES; BLAUTIA; CLINICAL ARTICLE; CONTROLLED STUDY; DYSBIOSIS; ENTEROBACTERIACEAE; ERYSIPELOTRICHACEAE; ESCHERICHIA; FEMALE; FUSOBACTERIA; HUMAN; HUMAN TISSUE; INTESTINE FLORA; LACHNOSPIRACEAE; LIVER FIBROSIS; MALE; MICROBIAL DIVERSITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; POPULATION ABUNDANCE; PREVOTELLA; PREVOTELLACEAE; PROTEOBACTERIA; RUMINOCOCCACEAE; SHIGELLA; STREPTOCOCCACEAE; TAXONOMY; BACTERIUM; CASE CONTROL STUDY; CLASSIFICATION; DISEASE EXACERBATION; FECES; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RIBOTYPING;

BACTERIAL DNA;

ADULT; BACTERIA; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA, BACTERIAL; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RIBOTYPING;

EID: 85027727040     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(17)60019-5     Document Type: Article

References (34)

1. Loomba, R, Sanyal, AJ, The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10 (2013), 686–690.
2. Aron-Wisnewsky, J, Gaborit, B, Dutour, A, Clement, K, Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect 19 (2013), 338–348.
3. Gangarapu, V, Yıldız, K, Ince, AT, Baysal, B, Role of gut microbiota: obesity and NAFLD. Turk J Gastroenterol 25 (2014), 133–140.
4. Compare, D, Coccoli, P, Rocco, A, Nardone, OM, De Maria, S, Cartenì, M, et al. Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22 (2012), 471–476.
5. Miele, L, Valenza, V, La Torre, G, Montalto, M, Cammarota, G, Ricci, R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49 (2009), 1877–1887.
6. Harte, AL, da Silva, NF, Creely, SJ, McGee, KC, Billyard, T, Youssef-Elabd, EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond), 7, 2010, 15.
7. Zhu, L, Baker, SS, Gill, C, Liu, W, Alkhouri, R, Baker, RD, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57 (2013), 601–609.
8. Go, GW, Oh, S, Park, M, Gang, G, McLean, D, Yang, HS, et al. t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation. J Microbiol Biotechnol 23 (2013), 1569–1576.
9. Dumas, ME, Barton, RH, Toye, A, Cloarec, O, Blancher, C, Rothwell, A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 103 (2006), 12511–12516.
10. Vijay-Kumar, M, Aitken, JD, Carvalho, FA, Cullender, TC, Mwangi, S, Srinivasan, S, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
11. De Minicis, S, Rychlicki, C, Agostinelli, L, Saccomanno, S, Candelaresi, C, Trozzi, L, et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology 59 (2014), 1738–1749.
12. Le Chatelier, E, Nielsen, T, Qin, J, Prifti, E, Hildebrand, F, Falony, G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
13. Fan, JG, Jia, JD, Li, YM, Wang, BY, Lu, LG, Shi, JP, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2011; 18:163-166). J Dig Dis 12 (2011), 38–44.
14. Wong, VW, Vergniol, J, Wong, GL, Foucher, J, Chan, HL, Le Bail, B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51 (2010), 454–462.
15. Karlas, T, Petroff, D, Garnov, N, Böhm, S, Tenckhoff, H, Wittekind, C, et al. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS One, 9, 2014, e91987.
16. Kleiner, DE, Brunt, EM, Van Natta, M, Behling, C, Contos, MJ, Cummings, OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
17. Schloss, PD, Westcott, SL, Ryabin, T, Hall, JR, Hartmann, M, Hollister, EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75 (2009), 7537–7541.
18. DeSantis, TZ Jr, Hugenholtz, P, Keller, K, Brodie, EL, Larsen, N, Piceno, YM, et al. NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res 34 (2006), W394–W399.
19. Wang, Q, Garrity, GM, Tiedje, JM, Cole, JR, Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73 (2007), 5261–5267.
20. Caporaso, JG, Kuczynski, J, Stombaugh, J, Bittinger, K, Bushman, FD, Costello, EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7 (2010), 335–336.
21. White, JR, Nagarajan, N, Pop, M, Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol, 5, 2009, e1000352.
22. Jiang, W, Wu, N, Wang, X, Chi, Y, Zhang, Y, Qiu, X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep, 5, 2015, 8096.
23. Croxen, MA, Law, RJ, Scholz, R, Keeney, KM, Wlodarska, M, Finlay, BB, Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 26 (2013), 822–880.
24. Purushe, J, Fouts, DE, Morrison, M, White, BA, Mackie, RI, North American Consortium for Rumen Bacteria, et al. Comparative genome analysis of Prevotella ruminicola and Prevotella bryantii: insights into their environmental niche. Microb Ecol 60 (2010), 721–729.
25. Zhu, L, Baker, RD, Baker, SS, Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res 77 (2015), 245–251.
26. Abdou, RM, Zhu, L, Baker, RD, Baker, SS, Gut microbiota of nonalcoholic fatty liver disease. Dig Dis Sci 61 (2016), 1268–1281.
27. Boursier, J, Mueller, O, Barret, M, Machado, M, Fizanne, L, Araujo-Perez, F, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63 (2016), 764–775.
28. Hvistendahl, M, My microbiome and me. Science 336 (2012), 1248–1250.
29. Clark, DP, The fermentation pathways of Escherichia coli. FEMS Microbiol Rev 5 (1989), 223–234.
30. Liu, J, Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol 20 (2014), 14672–14685.
31. Kameyama, K, Itoh, K, Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ 29 (2014), 427–430.
32. Zeng, H, Ishaq, SL, Zhao, FQ, Wright, AD, Colonic inflammation accompanies an increase of β-catenin signaling and Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice. J Nutr Biochem 35 (2016), 30–36.
33. Zhang, J, Guo, Z, Xue, Z, Sun, Z, Zhang, M, Wang, L, et al. A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J 9 (2015), 1979–1990.
34. Relman, DA, Restoration of the gut microbial habitat as a disease therapy. Nat Biotechnol 31 (2013), 35–37.